GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: compound 21 [WO2021053495A1]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: This compound is a bifunctional degrader of the cardiac-specific kinase TNNI3K protein, that is claimed in patent WO2021053495A1 [1]. It's kinase binding domain is derived from the quinazoline TNNI3K inhibitor GSK114 [2], and it contains a cereblon binding ligand to promote association with the protein-degrading E3 ubiquitin ligase complex.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
| References | 
| 
                                                                         1. Arista L, Broennimann V, D'Alessandro PL, Doumampoum-Metoul L, Goude M-L, Hebach C, Hollingworth GJ, Jeulin IKJ, Kirman LC, Lorber J et al.. (2021)
                                         Bifunctional degraders and their methods of use. Patent number: WO2021053495A1. Assignee: Novartis Ag. Priority date: 16/09/2019. Publication date: 25/03/2021.  | 
                                                                
| 
                                                                         2. Lawhorn BG, Philp J, Graves AP, Shewchuk L, Holt DA, Gatto Jr GJ, Kallander LS. (2016)
                                         GSK114: A selective inhibitor for elucidating the biological role of TNNI3K. Bioorg Med Chem Lett, 26 (14): 3355-3358. [PMID:27246618]  |